These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 11051232)

  • 1. Chronic daily low dose of 4-methyl-5-(2-pyrazinyl)-1,2-dithiole-3-thione (Oltipraz) in patients with previously resected colon polyps and first degree female relatives of breast cancer patients.
    Benson AB; Olopade OI; Ratain MJ; Rademaker A; Mobarhan S; Stucky-Marshall L; French S; Dolan ME
    Clin Cancer Res; 2000 Oct; 6(10):3870-7. PubMed ID: 11051232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and pharmacodynamics of oltipraz as a chemopreventive agent.
    Gupta E; Olopade OI; Ratain MJ; Mick R; Baker TM; Berezin FK; Benson AB; Dolan ME
    Clin Cancer Res; 1995 Oct; 1(10):1133-8. PubMed ID: 9815904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intermittent dosing with oltipraz: relationship between chemoprevention of aflatoxin-induced tumorigenesis and induction of glutathione S-transferases.
    Primiano T; Egner PA; Sutter TR; Kelloff GJ; Roebuck BD; Kensler TW
    Cancer Res; 1995 Oct; 55(19):4319-24. PubMed ID: 7671242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular kinetics of induction by oltipraz and its keto derivative of detoxication enzymes in human colon adenocarcinoma cells.
    O'Dwyer PJ; Clayton M; Halbherr T; Myers CB; Yao Ks
    Clin Cancer Res; 1997 May; 3(5):783-91. PubMed ID: 9815750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oltipraz: a laboratory and clinical review.
    Benson AB
    J Cell Biochem Suppl; 1993; 17F():278-91. PubMed ID: 8412206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional control of glutathione S-transferase gene expression by the chemoprotective agent 5-(2-pyrazinyl)-4-methyl-1,2-dithiole-3-thione (oltipraz) in rat liver.
    Davidson NE; Egner PA; Kensler TW
    Cancer Res; 1990 Apr; 50(8):2251-5. PubMed ID: 2317812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oltipraz chemoprevention trial in Qidong, People's Republic of China: modulation of serum aflatoxin albumin adduct biomarkers.
    Kensler TW; He X; Otieno M; Egner PA; Jacobson LP; Chen B; Wang JS; Zhu YR; Zhang BC; Wang JB; Wu Y; Zhang QN; Qian GS; Kuang SY; Fang X; Li YF; Yu LY; Prochaska HJ; Davidson NE; Gordon GB; Gorman MB; Zarba A; Enger C; Muñoz A; Helzlsouer KJ
    Cancer Epidemiol Biomarkers Prev; 1998 Feb; 7(2):127-34. PubMed ID: 9488587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic dosing of oltipraz in people at increased risk for colorectal cancer.
    Szarka CE; Yao KS; Pfeiffer GR; Balshem AM; Litwin S; Frucht H; Goosenberg EB; Engstrom PF; Clapper ML; O'Dwyer PJ
    Cancer Detect Prev; 2001; 25(4):352-61. PubMed ID: 11531012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection of retinal pigment epithelial cells from oxidative damage by oltipraz, a cancer chemopreventive agent.
    Nelson KC; Armstrong JS; Moriarty S; Cai J; Wu MW; Sternberg P; Jones DP
    Invest Ophthalmol Vis Sci; 2002 Nov; 43(11):3550-4. PubMed ID: 12407167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oltipraz concentrations in plasma, buccal mucosa cells, and lipids: pharmacological studies.
    Dimitrov NV; Leece CM; Tompkins ER; Seymour E; Bennink M; Gardiner J; Crowell J; Hawk E; Nashawaty M; Bennett JL
    Cancer Epidemiol Biomarkers Prev; 2001 Mar; 10(3):201-7. PubMed ID: 11303588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transient intervention with oltipraz protects against aflatoxin-induced hepatic tumorigenesis.
    Bolton MG; Muñoz A; Jacobson LP; Groopman JD; Maxuitenko YY; Roebuck BD; Kensler TW
    Cancer Res; 1993 Aug; 53(15):3499-504. PubMed ID: 8339253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of the chemopreventive agent oltipraz and of its metabolite M3 in human subjects after a single oral dose.
    O'Dwyer PJ; Szarka C; Brennan JM; Laub PB; Gallo JM
    Clin Cancer Res; 2000 Dec; 6(12):4692-6. PubMed ID: 11156221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer chemoprotection by oltipraz: experimental and clinical considerations.
    Helzlsouer KJ; Kensler TW
    Prev Med; 1993 Sep; 22(5):783-95. PubMed ID: 8234218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the cancer chemopreventive potency of dithiolethione analogs of oltipraz.
    Roebuck BD; Curphey TJ; Li Y; Baumgartner KJ; Bodreddigari S; Yan J; Gange SJ; Kensler TW; Sutter TR
    Carcinogenesis; 2003 Dec; 24(12):1919-28. PubMed ID: 14555609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the glutathione enzyme system of human colon mucosa by localisation, gender and age.
    Hoensch H; Peters WH; Roelofs HM; Kirch W
    Curr Med Res Opin; 2006 Jun; 22(6):1075-83. PubMed ID: 16846540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I/pharmacodynamic study of N-acetylcysteine/oltipraz in smokers: early termination due to excessive toxicity.
    Pendyala L; Schwartz G; Bolanowska-Higdon W; Hitt S; Zdanowicz J; Murphy M; Lawrence D; Creaven PJ
    Cancer Epidemiol Biomarkers Prev; 2001 Mar; 10(3):269-72. PubMed ID: 11303598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of radio-labeled N-Acetyl-L-Cysteine in Sprague-Dawley rats and its effect on glutathione metabolism following single and repeat dosing by oral gavage.
    Arfsten DP; Johnson EW; Wilfong ER; Jung AE; Bobb AJ
    Cutan Ocul Toxicol; 2007; 26(2):113-34. PubMed ID: 17612979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemoprevention of OH-BBN-induced bladder cancer in mice by oltipraz, alone and in combination with 4-HPR and DFMO.
    Moon RC; Kelloff GJ; Detrisac CJ; Steele VE; Thomas CF; Sigman CC
    Anticancer Res; 1994; 14(1A):5-11. PubMed ID: 8166455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oltipraz chemoprevention trial in Qidong, People's Republic of China: study design and clinical outcomes.
    Jacobson LP; Zhang BC; Zhu YR; Wang JB; Wu Y; Zhang QN; Yu LY; Qian GS; Kuang SY; Li YF; Fang X; Zarba A; Chen B; Enger C; Davidson NE; Gorman MB; Gordon GB; Prochaska HJ; Egner PA; Groopman JD; Muñoz A; Helzlsouer KJ; Kensler TW
    Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):257-65. PubMed ID: 9107431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oltipraz-induced phase 2 enzyme response conserved in cells lacking mitochondrial DNA.
    Chua YL; Zhang D; Boelsterli U; Moore PK; Whiteman M; Armstrong JS
    Biochem Biophys Res Commun; 2005 Nov; 337(1):375-81. PubMed ID: 16188238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.